Diabetes
News
Testing lab asks FDA to recall NDMA-tainted metformin
Some samples were found to have more than 10 times the safe daily limit for the impurity.
From the Journals
MACE benefits with dapagliflozin improve with disease duration
Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.
From the Journals
Latent diabetes warrants earlier, tighter glycemic control
Microvascular risks in adults with latent autoimmune diabetes increase with longer disease duration.
PURLs
NPH insulin: It remains a good option
NPH insulin holds its own against basal insulin analogs—and it’s cheaper.
Latest News
In gestational diabetes, early postpartum glucose testing is a winner
GRAPEVINE, TEX. – Inpatient postpartum testing captured 99 of 100 patients without sacrificing accuracy.
News
Dulaglutide OK for primary, secondary CV risk reduction in U.S.
This marks the first time a GLP-1 receptor agonist for type 2 diabetes has been approved for primary prevention of CV events.
From the Journals
Genetic risk score may flag post-GDM incidence of type 2 disease
A healthier diet might mitigate the increase in risk.
News
FDA opens the door to biosimilar insulin
The agency published a final rule that transitions insulin and other products from regulation as a drug to a biologic.
From the Journals
After gestational diabetes, longer lactation tied to lower risk for type 2
Epidemiologic data suggest that breastfeeding may reduce future diabetes risk, but mechanistic work needs to be done.
From the Journals
Sharpest spikes in pediatric diabetes seen in Asian, Pacific Islander youth
Rates are generally higher in racial and ethnic minorities, although low in American Indian youth.
Conference Coverage
Tools for preventing heart failure
SNOWMASS, COLO. – “There will be more than 1 million new cases of heart failure this year, and the vast majority of them could have been prevented...